Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.25 | 8e-07 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |